Medicine
Sodium fluoride f-18 600 mCi/mL injection
Sodium fluoride f-18 600 mCi/mL injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F) in a shielded container, excursions permitted to 15-30°C…
Key facts
- Active ingredient (INN)
- Sodium fluoride f-18
- Brand
- Sold under the generic name
- Strength
- 600 mCi/mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 20 mL
- Manufacturer
- The Feinstein Institutes for Medical Research
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F) in a shielded container, excursions permitted to 15-30°C (59-86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 19 November 2014
- Identifiers
- DailyMed set ID f8afb06c-f4c3-46f0-8f8b-0bc9e072ce47NDC 13267-542Application ANDA204328
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 20 mL in 1 vial, glass | 13267-542-42 | The Feinstein Institutes for Medical Research | 19 November 2014 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 24 February 1972 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Sodium fluoride f-18
Clinical summary
Sodium fluoride f-18 is a radioactive diagnostic agent indicated for diagnostic positron emission tomography (PET) imaging of bone to define areas of altered osteogenic activity. It is available as injection for intravenous use. MedsAcross supplies Sodium fluoride f-18 for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Sodium fluoride f-18For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Sodium Fluoride F 18 prescribing information (Sofie) · U.S. National Library of Medicine, DailyMed
Need Sodium fluoride f-18 600 mCi/mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.